DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00243438|
Recruitment Status : Completed
First Posted : October 24, 2005
Last Update Posted : January 28, 2009
|Condition or disease||Intervention/treatment|
|Coronary Disease||Device: Multilink Vision™ Stent (CE-labeled)|
|Study Type :||Observational|
|Enrollment :||1300 participants|
|Official Title:||Distinctly Access Vision In Coronary Interventions|
|Study Start Date :||July 2003|
|Actual Primary Completion Date :||March 2005|
|Actual Study Completion Date :||March 2005|
Patients who have received a Vision stent and who have diabetes and/or complex lesions.
Device: Multilink Vision™ Stent (CE-labeled)
Patients who have diabetes and/or complex lesions and who have had a Multilink Vision™ Stent placed.
- TVF [ Time Frame: 9 months ]
- Mode of death
- Time to first MI
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00243438
|Bad Nauheim, Germany, 61231|
|Principal Investigator:||Christian Hamm, MD||Kerckhoff-Klinik/ Benekestr. 2-8/ 61231 Bad Nauheim|